The explanation for the repression of RARβ expression in D19, D20, and D34 was promoter hypermethylation, emphasising epigenetic mechanisms in oral cancer pathogenesis, and the importance of the combination of drugs for chemoprevention. Here, RARB is linked to lip and oral cavity carcinoma.